News

• Date
• Topic

• 2026-01-28
• NewTaiGen and Boryung Biopharma Hold Signing Ceremony for Influenza Drug Pixavir Partnership

• 2026-01-26
• NewTaiGen Licenses Influenza Antiviral to South Korea’s Boryung Biopharma

• 2025-12-12
• NewTaiGen In-Licenses Insilico Medicine’s AI-driven CKD Anemia Drug ISM4808

• 2025-12-11
• NewTaiGen's Pixavir Receives NMPA Approval in China, Targets Influenza Market

• 2025-10-23
• NewTaiGen Licenses Antiviral Pixavir marboxil in India

• 2025-10-01
• TaiGen Expands into Vietnam with Taigexyn® Licensing Deal

• 2025-03-20
• TaiGen's Flu Antiviral Pediatric Formulation Submitted For IND in China

• 2025-02-11
• TaiGen's New Single-Dose Flu Drug Targets Global Markets

• 2024-12-30
• TaiGen Taigexyn® (Nemonoxacin) Filed NDA in Malaysia

• 2024-08-05
• NDA Submitted for TaiGen Influenza Antiviral TG-1000 in Mainland China